Clomid is one of the most common names you’ll see when researching PCT. Clomid (Clomiphene Citrate) is a powerful SERM with anti-oestrogen effects and was originally developed as a fertility medication for women who do not ovulate normally. Clomid is also sometimes prescribed for the treatment of hypogonadism in men as an alternative option to testosterone replacement therapy, with excellent results often seen. Whilst Clomid produces a variety of beneficial results, Clomid is most highly regarded for boosting testosterone.
Dosage: 50mg / ml
WHAT THIS PRODUCT IS BEST FOR
After the completion of a SARMs cycle, you may notice a considerable rise in oestrogen which naturally decreases testosterone levels. Clomid is designed to mitigate this from occurring and assists in boosting testosterone levels. Clomid is the better known SERM for helping prevent / reduce Gynecomastia aka ‘man boobs’ due to it being able to reduce water retention.
- Boosts testosterone
- Reduces oestrogen levels
- Helps reduce water retention (which in turn can help prevent gyno)
- Balances out endogenous testosterone
- Lowers cortisol levels
HOW TO TAKE IT
Oral form of administering.
Individual timeframes and dosages can be recommended by a medical practitioner.
CLOMID VS NOLVADEX FOR PCT
Experienced body builders / athletes will use both Clomid and Nolvadex in PCT whilst often also combining these with HCG to kickstart the natural testosterone production process.
The debate on whether Clomid or Nolvadex is the better option has been going for years and is solely dependent on your unique, personal circumstances and body type.
Clomid is often thought of as a more effective testosterone booster, whilst Nolvadex is seen as a better oestrogen blocker. Due to them both being anti-oestrogens, they both stimulate the release of GnRH which increases the output of luteinizing hormone by the pituitary gland which then leads to an increase in testosterone levels.
The most effective use of these SERMs is when combined with the guidance of a medical practitioner.